更正：癌症干细胞（CD44/CD24）、RAD6、DDB2免疫组织化学表达及IHC-UNEDO评分系统作为卵巢癌化疗耐药的预测指标
Correction: Cancer Stem Cells (CD44/CD24), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer Chemoresistance.
作者信息
Sihombing Unedo Hence Markus, Andrijono Andrijono, Purwoto Gatot, Gandamihardja Supriadi, Harahap Alida R, Rustamadji Primariadewi, Kekalih Aria, Widyawati Retno, Fuady Dzicky Rifqi
机构信息
Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Tarakan Hospital, Jakarta, Indonesia.
Gynecologic-Oncology Division, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
出版信息
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):650. doi: 10.1007/s13224-024-01987-5. Epub 2024 Apr 8.
Abstract
[This corrects the article DOI: 10.1007/s13224-023-01829-w.].
摘要
[本文更正了文章的数字对象标识符：10.1007/s13224-023-01829-w。]
相似文献
1
Correction: Cancer Stem Cells (CD44/CD24), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer Chemoresistance.
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):650. doi: 10.1007/s13224-024-01987-5. Epub 2024 Apr 8.
2
Cancer Stem Cells (CD44/CD24), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer Chemoresistance.
J Obstet Gynaecol India. 2024 Jun;74(3):236-242. doi: 10.1007/s13224-023-01829-w. Epub 2023 Dec 19.
3
Expression of CD44/CD24, RAD6 and DDB2 on chemotherapy response in ovarian Cancer: A prospective flow cytometry study.
Gynecol Oncol Rep. 2022 Jun 3;42:101005. doi: 10.1016/j.gore.2022.101005. eCollection 2022 Aug.
4
CD44/CD24 Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study.
J Egypt Natl Canc Inst. 2022 Oct 24;34(1):44. doi: 10.1186/s43046-022-00143-2.
5
Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
Biochem Biophys Res Commun. 2013 May 17;434(4):898-903. doi: 10.1016/j.bbrc.2013.04.053. Epub 2013 Apr 23.
6
Expression of cancer stem cell markers (CD24, CD44 & ALDH1A3 isoform) in Breast Cancer in Indian population considering clinicopathological characteristics and response to neoadjuvant chemotherapy - a prospective analysis from a university hospital.
Indian J Surg Oncol. 2024 Dec;15(4):874-883. doi: 10.1007/s13193-024-02013-w. Epub 2024 Jul 5.
7
p63 inhibits CD44/CD24 cell proliferation and chemoresistance in papillary thyroid carcinoma cells.
Exp Ther Med. 2017 Nov;14(5):4693-4696. doi: 10.3892/etm.2017.5137. Epub 2017 Sep 19.
8
Are CD44/CD24 cells the assumed cancer stem cells in breast cancer?
Exp Oncol. 2017 Sep;39(3):224-228.
9
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
Oncogene. 2017 Nov 30;36(48):6680-6690. doi: 10.1038/onc.2017.279. Epub 2017 Aug 14.
10
The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
Ann Diagn Pathol. 2021 Apr;51:151696. doi: 10.1016/j.anndiagpath.2020.151696. Epub 2021 Jan 14.
Zotero 插件